Nucleos(t)ide Therapy for TK2-Deficient Mitochondrial Myopathy: Small Molecules With Big Potential.

Creator(s)

Jennifer L. Gannon, Children's Mercy HospitalFollow

Document Type

Editorial

Publication Date

9-23-2025

Identifier

DOI: 10.1212/WNL.0000000000214187

Journal Title

Neurology

Volume

105

Issue

6

First Page

214187

Last Page

214187

PubMed ID

40911820

Recommended Citation

Gannon JL. Nucleos(t)ide Therapy for TK2-Deficient Mitochondrial Myopathy: Small Molecules With Big Potential. Neurology. 2025;105(6):e214187. doi:10.1212/WNL.0000000000214187